US Patent Issued to Immunity Pharma on Sept. 29 for "Compositions and methods of using same for treating amyotrophic lateral sclerosis (ALS)" (Israeli Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,267, issued on Sept. 29, was assigned to Immunity Pharma Ltd. (Mevasseret Zion, Israel).

"Compositions and methods of using same for treating amyotrophic lateral sclerosis (ALS)" was invented by Eran Ovadia (Mevasseret Zion, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods of using same for treating Amyotrophic Lateral Sclerosis (ALS) are provided. Accordingly there is provided a method of treating ALS in a human subject in need thereof, the method comprising intravenously (IV) administering to the subject 2-5 mg/kg of a peptide comprising an amino acid sequence as set forth in SEQ ID NO: 1. Also provided are compositi...